ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

TNXP // Tonix Pharmaceuticals Holding Corp.

SPLC <GO> NASDAQ RQD COCKPIT → CIK 0001430306 ↗
Health Care • Biotechnology: Pharmaceutical Preparations
$5.15 ▲ +0.05 (+0.98%)
MKT CAP: $88.3M • VOL: 622.6K
TNXP // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO> CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NASDAQ
TNXP // Tonix Pharmaceuticals Holding Corp.
GROSS MARGIN
49.3%
OP MARGIN
-60.0%
ROIC %
-35.0%
MKT CAP
$88.3M
UPSTREAM INPUTS ──► TNXP OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO> REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO> REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON
TICKER COMPANY LAST MKT CAP GROSS MGN OP MGN ROIC % EV/EBITDA REV YOY HEAD-TO-HEAD
TNXP ★ Tonix Pharmaceuticals Holding Corp. $5.15 $88.3M 49.3% -60.0% -35.0% — +29.8% SUBJECT ISSUER
LLY Eli Lilly and Company $1,410.99 $1.33T 83.6% 40.2% 32.4% 36.2x +45.5% TNXP VS LLY <GO>
JNJ Johnson & Johnson $270.56 $651.32B 67.9% 34.7% 25.5% 18.5x +6.0% TNXP VS JNJ <GO>
ABBV AbbVie Inc. $288.84 $510.41B 70.2% 24.6% 29.0% 33.3x +8.6% TNXP VS ABBV <GO>
MRK Merck & Company Inc. $148.36 $366.03B 74.8% 34.3% 20.7% 15.3x +1.3% TNXP VS MRK <GO>
UNH UnitedHealth Group Incorporated $400.44 $359.43B 88.3% 5.3% 12.4% 15.3x +3.3% TNXP VS UNH <GO>